8-K: BIOLASE, Inc. Reports Total Shares Outstanding
Current Report
BIOLASE, Inc. disclosed that as of February 19, 2024, it had 23,334,852 shares of common stock issued and outstanding.
Summary
- BIOLASE, Inc. filed a Form 8-K report on February 20, 2024.
- The report disclosed the total number of common stock shares issued and outstanding.
- As of February 19, 2024, the company had 23,334,852 shares of common stock outstanding.
Sentiment
Score: 5
Explanation: The document is a neutral disclosure of share information, neither positive nor negative.
Industry Context
This is a standard disclosure for publicly traded companies to keep investors informed about the company's capital structure.
Comparison to Industry Standards
- Public companies regularly report their outstanding share counts in SEC filings.
- This disclosure is consistent with standard reporting practices for companies listed on the Nasdaq Capital Market.
- Comparable companies would also be expected to disclose their outstanding share counts in similar filings.
Stakeholder Impact
- This information is relevant to shareholders as it provides an update on the company's capital structure.
Key Dates
| Date | Description |
|---|---|
| February 19, 2024 | Date for which the total number of outstanding shares was reported. |
| February 20, 2024 | Date of the 8-K filing. |
| February 21, 2024 | Date the report was signed by the CEO. |
Keywords
common stock, shares outstanding, BIOLASE, Form 8-K, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.